Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests safer anesthesia for elderly hip fracture patients

NCT ID NCT07358299

Symptom relief Sponsor: Centre of Postgraduate Medical Education Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two spinal anesthesia methods for hip fracture surgery in people over 50. One method uses a single injection, the other uses a tiny tube to give the medicine in smaller doses. The goal is to see if the tube method causes fewer drops in blood pressure and related problems like confusion or kidney injury. About 216 participants will be randomly assigned to one of the two groups and followed for up to 24 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Bupivacaine (spinal anesthetic)
What this could lead to
If successful, this could show that continuous spinal anesthesia is safer for elderly hip fracture patients, reducing risks like low blood pressure and confusion.
What could go wrong
This is a Phase 4 trial, but it's not yet recruiting. The benefits may not be large enough to change standard practice, and the catheter technique carries its own infection or nerve injury risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 216 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2026

An estimate. Start dates often move.

Expected to finish

Nov 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age \> 50 years, regardless of gender * Diagnosis of a proximal femur fracture * Orthopedic qualification for open reduction and internal fixation of the fracture * Informed consent for the surgical procedure * Informed consent for regional anesthesia, i.e., a central neuraxial block (spinal anesthesia) * Informed consent to participate in the study Exclusion Criteria: * Age \< 50 years, regardless of gender * Refusal to consent to surgical treatment * Refusal to consent to regional anesthesia * Refusal to consent to participate in the study * Inability to provide informed consent * Allergy to local anesthetic agents * Severe congenital or acquired coagulation disorders * Failure to meet the recommended time interval between the last dose of an anticoagulant and central neuraxial blockade, according to the 2022 European Journal of Anaesthesiology (EJA) guidelines * Infection at the block site or a systemic infection (i.e., sepsis, septic shock) * Patients with multiple organ dysfunction syndrome requiring hospitalization in the Intensive Care Unit for stabilization of vital functions * Clinical signs of increased intracranial pressure or suspicion of an intracranial mass on imaging studies * Other contraindications to spinal anesthesia as judged by the qualifying physician

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anesthesia, spinal are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hip fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anesthesia, spinal Hip fractures

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre of Postgraduate Medical Education, Professor A. Gruca Teaching Hospital, Konarskiego 13 street

    Otwock, 05-400, Poland

  • National Medical Institute of the Ministry of the Interior and Administration, Wołoska 137 street

    Warsaw, 02507, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.